Active — Not RecruitingNot Applicable

Imaging Quantification of Inflammation (IQI)

United States50 participantsStarted 2019-09-22

Plain-language summary

1\. Perform observational study utilizing real-time quantification of ocular inflammation to determine minimal important change. Prospective use of changes in imaging quantification of inflammation (IQI) scores in determining treatment decisions both utilizing novel FA viewer software.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any patient with a diagnosis of uveitis, who is deemed active or recently active (6 months) by a uveitis specialist Exclusion Criteria: * Poor view in fundus in both eyes which precludes image acquisition in those with posterior uveitis * Those with posterior uveitis, any allergy to fluorescein * Corneal opacities which prevent image acquisition * Inability to sign consent

What they're measuring

Real Time Quantification of Ocular inflammation

Timeframe: 6 months

Trial details

NCT IDNCT04704609

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-04-20

View on ClinicalTrials.gov More Uveitis trials